Blocking Babesia bovis vaccine reactions of dairy cattle in milk

Onderstepoort Journal of Veterinary Research

 
 
Field Value
 
Title Blocking Babesia bovis vaccine reactions of dairy cattle in milk
 
Creator Combrink, Michael P. Carr, Graham Mans, Ben J. Marais, Frances
 
Subject Veterinary Research Babesia bovis; Babesia bigemina; blood vaccine; diminazene; dairy cattle
Description The use of 1.16 mg/kg (one third) of the recommended dose of diminazene aceturate, administered indiscriminately to cattle on day seven of the unfrozen Babesia bovis and Babesia bigemina bivalent live blood vaccine reaction, was an infection and block treatment method of immunisation used successfully with no known adverse effect on the parasites or the development of protective immunity. Continuing with this practice after replacement of the unfrozen vaccine with deep-frozen monovalent B. bovis and B. bigemina live blood vaccines resulted in reports of vaccine failure. Laboratory investigation indicated the harmful effect of block treatment in preventing the development of durable immunity against B. bigemina as opposed to the much lesser effect it had on B. bovis. Consequently the practice was no longer recommended. A B. bovis vaccination attempt aimed at controlling the disease of dairy cows in milk (n = 30) resulted in 20% fatalities during the expected vaccine reaction period. The practice of block treating B. bovis was therefore reinvestigated, this time in a field trial using dairy cattle in milk (n = 11). Using 0.88 mg/kg (one quarter) of the recommended dose of diminazene administered on day 12 of the B. bovis vaccine reaction resulted in only two animals (n = 5) testing ≥ 1/80 positive with the indirect fluorescent antibody test (IFAT) although parasites could be demonstrated in three. In the untreated control group, by contrast, five of the vaccinated animals (n = 6) tested ≥ 1/80 positive with IFAT and parasites could be demonstrated in all. The unsatisfactory outcome obtained in this study, combined with that of the earlier investigation, indicated that there are more factors that influence successful vaccination than previously considered. It is therefore concluded that block treatment of the live frozen South African cattle babesiosis vaccines reactions is not recommended.
 
Publisher AOSIS
 
Contributor
Date 2012-12-06
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/octet-stream text/xml application/pdf
Identifier 10.4102/ojvr.v79i1.491
 
Source Onderstepoort Journal of Veterinary Research; Vol 79, No 1 (2012); 4 pages 2219-0635 0030-2465
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ojvr.org/index.php/ojvr/article/view/491/752 https://ojvr.org/index.php/ojvr/article/view/491/753 https://ojvr.org/index.php/ojvr/article/view/491/754 https://ojvr.org/index.php/ojvr/article/view/491/722
 
Coverage — — —
Rights Copyright (c) 2012 Michael P. Combrink, Graham Carr, Ben J. Mans, Frances Marais https://creativecommons.org/licenses/by-nd/4.0
ADVERTISEMENT